La Palma, CA5 Active Studies

Ankylosing Spondylitis Clinical Trials in La Palma, CA

Find 5 actively recruiting ankylosing spondylitis clinical trials in La Palma, CA. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
4,883
Enrolling

Recruiting Ankylosing Spondylitis Studies in La Palma

RecruitingLa Palma, CANCT06052267

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

The primary objective of the study is to assess the efficacy of high dose and low dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic module multidose dry powder inhaler (eM...

2,196 participants
Teva Branded Pharmaceutical Products R&D, Inc.
View Study Details
RecruitingLa Palma, CANCT05763121

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.

This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma with an eosinophilic phenotype and a history of asthm...

1,395 participants
Areteia Therapeutics
View Study Details
RecruitingLa Palma, CANCT06664619

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are...

724 participants
Teva Branded Pharmaceutical Products R&D, Inc.
View Study Details
RecruitingLa Palma, CANCT06376045

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....

428 participants
Amgen
View Study Details
RecruitingLa Palma, CANCT06293365

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

The purpose of this study is to demonstrate the comparability of ianalumab exposure following the sub-cutaneous (s.c.) administration of one injection of 300 mg/2 mL auto-injector (AI) versus two inje...

140 participants
Novartis Pharmaceuticals
View Study Details

About Ankylosing Spondylitis Clinical Trials in La Palma

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 5 ankylosing spondylitis clinical trials recruiting participants in La Palma, CA. These studies are seeking a combined 4,883 participants. Research is being sponsored by Teva Branded Pharmaceutical Products R&D, Inc., Areteia Therapeutics, Amgen and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in La Palma — FAQ

Are there ankylosing spondylitis clinical trials in La Palma?

Yes, there are 5 ankylosing spondylitis clinical trials currently recruiting in La Palma, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in La Palma?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the La Palma research site will contact you about next steps.

Are clinical trials in La Palma free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many La Palma studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 5 active trials in La Palma are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov